Practice question

Answer the question and get instant feedback.

Hardand lower CV risk; preferred add-on to metformin and SGLT2i in ASCVD. DPP‑4ASCVDor insulin lack the same benefit profile."

A 61-year-old with T2D and ASCVD on metformin and SGLT2i has A1c 8.4%. Weight 104 kg (BMI 34). Best add-on?

Educational content. Not a substitute for clinical judgement or local policy.